ResMed (RMD) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $253.06 --0%
Revenue Growth %: +6.9%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
RCBC, SSL, PFBC, More
Revenue Growth %: +6.9%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
RCBC, SSL, PFBC, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.64, $0.03 better than the analyst estimate of $1.61. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.1 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Upgrades ABB Ltd (ABB) to Outperform
- Investar Holding (ISTR) Tops Q3 EPS by 1c
- Commercial National Financial (CNAF) Reports Q3 EPS of $0.24
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
